India has introduced a new cancer treatment that could change the way many lung cancer patients receive immunotherapy. Roche Pharma India has launched a new subcutaneous injection version of its ...
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results